September 17, 2021 -- Infinity Biologix (IBX) has acquired U.K.-based Roylance Pharma to strengthen client support and accelerate growth, the company announced.
IBX company leaders said the acquisition will help establish a biobanking and bioprocessing hub in the U.K. that will service Europe.